Lilly: 150 years transforming what medicine can do next

▤ Summary

Lilly marks 150 years by highlighting its role in industrializing key medicines and building a global pharmaceutical business. The article revisits major milestones such as large-scale insulin production, penicillin manufacturing, polio vaccine distribution, and early oncology and mental health treatments. It also shows how Lilly is using AI and a major NVIDIA partnership to speed drug discovery, clinical trials, and production. In Portugal, the company points to long approval and access delays as a major barrier and argues for faster, more equitable access to innovation. The piece frames obesity and Alzheimer’s as long-term strategic priorities for the next phase of Lilly’s research and treatment work.

▦ Linked Companies

NVIDIA Corporation

$1B+